1. Home
  2. KRO vs OMER Comparison

KRO vs OMER Comparison

Compare KRO & OMER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kronos Worldwide Inc

KRO

Kronos Worldwide Inc

N/A

Current Price

$8.16

Market Cap

1.0B

Sector

Industrials

ML Signal

N/A

Logo Omeros Corporation

OMER

Omeros Corporation

N/A

Current Price

$17.50

Market Cap

1.2B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
KRO
OMER
Founded
1916
1994
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.2B
IPO Year
2004
2008

Fundamental Metrics

Financial Performance
Metric
KRO
OMER
Price
$8.16
$17.50
Analyst Decision
Hold
Buy
Analyst Count
2
3
Target Price
$8.50
★ $27.50
AVG Volume (30 Days)
320.0K
★ 1.0M
Earning Date
11-05-2026
11-16-2026
Dividend Yield
★ 2.38%
N/A
EPS Growth
N/A
★ 98.15
EPS
0.39
★ 0.77
Revenue
★ $1,859,400,000.00
$29,868,000.00
Revenue This Year
$11.05
N/A
Revenue Next Year
$1.77
$73.59
P/E Ratio
★ $21.42
$23.42
Revenue Growth
★ N/A
N/A
52 Week Low
$4.29
$6.70
52 Week High
$9.17
$21.24

Technical Indicators

Market Signals
Indicator
KRO
OMER
Relative Strength Index (RSI) 56.51 48.07
Support Level $8.08 $16.33
Resistance Level $8.91 $19.68
Average True Range (ATR) 0.40 0.95
MACD 0.11 0.04
Stochastic Oscillator 75.68 42.53

Price Performance

Historical Comparison
KRO
OMER

About KRO Kronos Worldwide Inc

Kronos Worldwide Inc manufactures and sells titanium dioxide pigments. Titanium dioxide is a white inorganic pigment used in various products. The majority of Kronos' sales come from titanium dioxide used for coatings on automobiles, aircraft, machines, appliances, traffic paint, and in both commercial and residential interiors and exteriors. The second product category is titanium dioxide used for plastics such as packaging materials and food packaging, houseware, appliances, toys, and computer cases. The maximum of revenue comes from the United States.

About OMER Omeros Corporation

Omeros Corp is an inventive, commercial-stage biotechnology company that discovers and develops first-in-class protein and small-molecule therapeutics for large-market and orphan indications, with particular emphasis on complement-mediated diseases, cancers, and addictive or compulsive disorders. The company's clinical-stage development programs include: narsoplimab, its antibody targeting mannan-binding lectin-associated serine protease 2 (MASP-2), the effector enzyme of the lectin pathway of complement; OMS1029, its long-acting antibody targeting MASP-2; and OMS527, its phosphodiesterase 7 (PDE7) inhibitor program.

Share on Social Networks: